Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression
Kai Yin, Xueli Xia, Ke Rui, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease
Tapas Mukherjee, Naveen Kumar, M. L. Chawla, et al.
Science Signaling (2024) Vol. 17, Iss. 818
Closed Access | Times Cited: 43
Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021
Long Ma, Jixiang Ma, Muzhou Teng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 57
Mechanism and strategies of immunotherapy resistance in colorectal cancer
Jiqi Shan, Dong Han, Chunyi Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research (2023) Vol. 233, pp. 116458-116458
Closed Access | Times Cited: 23
Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine
Pankaj Ahluwalia, Kalyani Ballur, Tiffanie Leeman, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 480-480
Open Access | Times Cited: 14
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
Kai He, Xi Liu, Robert D. Hoffman, et al.
FEBS Open Bio (2022) Vol. 12, Iss. 7, pp. 1268-1285
Open Access | Times Cited: 33
The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update
Maysaloun Merhi, Fareed Ahmad, Nassiba Taib, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 1-17
Open Access | Times Cited: 22
Mechanisms of colorectal liver metastasis development
Tal Shasha, Mandy Gruijs, Marjolein van Egmond
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 25
The oral-gut-circulatory axis: from homeostasis to colon cancer
Sofia C. Tortora, Maria Gonzalez Agurto, Laura Martello
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Decreased interleukin‐17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice
Jeng‐Kai Jiang, Chi‐Hung Lin, Ting‐An Chang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 4
Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy
Chen Chen, Peixin Tan, Wenqing Feng, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 3
Open Access
The Dynamic Changes of Circulating Myeloid-Derived Suppressor Cells (MDSCs) Subsets in Colorectal Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy
Ralph Girson Gunarsa, Aru Wisaksono Sudoyo, Ricci Steven, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Necrostatin‐1 attenuates oral squamous cell carcinoma by modulating tumour immune response in mice
L. Saravanan, Ashutosh Mahale, Vikram Gota, et al.
Fundamental and Clinical Pharmacology (2025) Vol. 39, Iss. 3
Closed Access
Role of reactive oxygen species in tumors based on the ‘seed and soil’ theory: A complex interaction (Review)
Wei Liang, Xinying He, Jianqiang Bi, et al.
Oncology Reports (2021) Vol. 46, Iss. 3
Open Access | Times Cited: 21
Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies
Shu-Chang Nie, Yanhua Jing, Lu Lu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 5, pp. 1690-1704
Open Access | Times Cited: 3
Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis
Ju Chen, Neha Singh, X Ye, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 7, pp. 1007-1017
Open Access | Times Cited: 3
Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Wenqin Luo, Wenqiang Xiang, Lu Gan, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
Mohammad A. Al-Mterin, Eyad Elkord
Exploration of Targeted Anti-tumor Therapy (2022), pp. 497-510
Open Access | Times Cited: 12
Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors
Refaat A. Eid, Muhammad Alaa Eldeen, Mohamed A. Soltan, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 7
Microbiota-associated mechanisms in colorectal cancer
Adriana González, Asier Fullaondo, Adrián Odriozola
Advances in genetics (2024), pp. 123-205
Closed Access | Times Cited: 2
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
Rinku Dutta, Roukiah Khalil, Karthick Mayilsamy, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 14
Unlocking PD‐1 antibody resistance: The MUC1 DNA vaccine augments CD8+ T cell infiltration and attenuates tumour suppression
Xiaoqin Wang, Yinsha Miao, Jinghui Shen, et al.
Scandinavian Journal of Immunology (2024) Vol. 99, Iss. 5
Closed Access | Times Cited: 1
LC3-dependent extracellular vesicles promote M-MDSC accumulation and immunosuppression in colorectal cancer
Ye Gu, Qiang Liu, Qiaoxian He, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109272-109272
Open Access | Times Cited: 1
Review of METTL3 in colorectal cancer: From mechanisms to the therapeutic potential
Lexuan Zhang, Zhenwei Mao, Kai Yin, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134212-134212
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top